Titre : Ellipticines

Ellipticines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Time Management

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une tumeur sensible aux ellipticines ?

Un diagnostic est établi par biopsie et analyses histopathologiques.
Tumeurs Biopsie
#2

Quels tests sont utilisés pour évaluer l'efficacité des ellipticines ?

Des tests d'imagerie comme l'IRM et des marqueurs tumoraux sont utilisés.
Imagerie par résonance magnétique Marqueurs tumoraux
#3

Les ellipticines sont-elles utilisées pour tous les types de cancer ?

Non, elles sont principalement efficaces contre certains cancers comme le cancer du poumon.
Cancer du poumon Anticancéreux
#4

Quels signes cliniques indiquent un traitement par ellipticines ?

Des signes de progression tumorale ou de résistance aux autres traitements peuvent indiquer leur utilisation.
Résistance aux médicaments Progression tumorale
#5

Comment évaluer les effets secondaires des ellipticines ?

Les effets secondaires sont évalués par des examens cliniques et des questionnaires de qualité de vie.
Effets secondaires Qualité de vie

Symptômes 5

#1

Quels symptômes peuvent indiquer un cancer traité par ellipticines ?

Les symptômes incluent douleur, fatigue, perte de poids et changements d'appétit.
Symptômes Fatigue
#2

Les ellipticines provoquent-elles des effets secondaires ?

Oui, elles peuvent causer nausées, vomissements, et troubles hématologiques.
Nausées Troubles hématologiques
#3

Comment reconnaître une réaction allergique aux ellipticines ?

Des éruptions cutanées, démangeaisons ou gonflements peuvent indiquer une allergie.
Réaction allergique Éruption cutanée
#4

Les ellipticines affectent-elles le système immunitaire ?

Oui, elles peuvent entraîner une immunosuppression, augmentant le risque d'infections.
Immunosuppression Infections
#5

Quels signes indiquent une toxicité des ellipticines ?

Des signes de toxicité incluent fatigue extrême, saignements inhabituels et jaunisse.
Toxicité Jaunisse

Prévention 5

#1

Peut-on prévenir les cancers traités par ellipticines ?

Certaines mesures préventives incluent un mode de vie sain et des dépistages réguliers.
Prévention du cancer Dépistage
#2

Quels facteurs de risque sont associés aux cancers traités par ellipticines ?

Les facteurs incluent le tabagisme, l'exposition à des agents carcinogènes et des antécédents familiaux.
Facteurs de risque Tabagisme
#3

Les vaccinations peuvent-elles aider à prévenir le cancer ?

Oui, certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer.
Vaccination HPV
#4

Comment un mode de vie sain influence-t-il le risque de cancer ?

Un mode de vie sain, incluant alimentation équilibrée et exercice, peut réduire le risque.
Mode de vie sain Alimentation équilibrée
#5

Les examens de santé réguliers sont-ils importants ?

Oui, ils permettent de détecter précocement des anomalies et d'initier un traitement rapide.
Examens de santé Détection précoce

Traitements 5

#1

Comment les ellipticines sont-elles administrées ?

Elles sont généralement administrées par voie intraveineuse ou orale.
Administration intraveineuse Voie orale
#2

Les ellipticines sont-elles utilisées en monothérapie ?

Elles peuvent être utilisées seules ou en association avec d'autres traitements anticancéreux.
Monothérapie Thérapie combinée
#3

Quel est le mécanisme d'action des ellipticines ?

Elles agissent en interférant avec l'ADN des cellules cancéreuses, inhibant leur prolifération.
Mécanisme d'action Inhibition de la prolifération
#4

Quelles sont les alternatives aux ellipticines ?

Les alternatives incluent d'autres chimiothérapies, thérapies ciblées et immunothérapies.
Chimiothérapie Thérapies ciblées
#5

Comment surveiller l'efficacité du traitement par ellipticines ?

L'efficacité est surveillée par des examens d'imagerie et des bilans sanguins réguliers.
Surveillance Examens d'imagerie

Complications 5

#1

Quelles complications peuvent survenir avec les ellipticines ?

Les complications incluent des infections, des saignements et des réactions allergiques.
Complications Infections
#2

Les ellipticines peuvent-elles causer des dommages aux organes ?

Oui, elles peuvent entraîner des toxicités hépatiques et rénales, nécessitant une surveillance.
Toxicité hépatique Toxicité rénale
#3

Comment gérer les effets secondaires graves des ellipticines ?

La gestion inclut l'ajustement de la dose, l'utilisation de médicaments symptomatiques et le suivi.
Gestion des effets secondaires Ajustement de dose
#4

Les ellipticines augmentent-elles le risque de récidive du cancer ?

Elles peuvent réduire le risque de récidive, mais un suivi régulier est essentiel.
Récidive du cancer Suivi régulier
#5

Quels sont les risques de surdosage d'ellipticines ?

Le surdosage peut entraîner des effets toxiques graves, nécessitant une intervention médicale immédiate.
Surdosage Intervention médicale

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque pour les cancers traités par ellipticines ?

Les principaux facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'âge.
Facteurs de risque Tabagisme
#2

L'hérédité joue-t-elle un rôle dans le risque de cancer ?

Oui, des antécédents familiaux de cancer augmentent le risque de développer certaines tumeurs.
Hérédité Antécédents familiaux
#3

L'alimentation influence-t-elle le risque de cancer ?

Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers.
Alimentation Fruits et légumes
#4

Le stress est-il un facteur de risque pour le cancer ?

Bien que le stress ne soit pas un facteur direct, il peut affecter le système immunitaire.
Stress Système immunitaire
#5

Les infections virales augmentent-elles le risque de cancer ?

Oui, certaines infections virales, comme le HPV, sont liées à un risque accru de cancer.
Infections virales HPV
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Ellipticines : Questions médicales les plus fréquentes", "headline": "Ellipticines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Ellipticines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-02", "dateModified": "2025-03-29", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Ellipticines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carbazoles", "url": "https://questionsmedicales.fr/mesh/D002227", "about": { "@type": "MedicalCondition", "name": "Carbazoles", "code": { "@type": "MedicalCode", "code": "D002227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.148" } } }, "about": { "@type": "MedicalCondition", "name": "Ellipticines", "alternateName": "Ellipticines", "code": { "@type": "MedicalCode", "code": "D004611", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elaine C O'Sullivan", "url": "https://questionsmedicales.fr/author/Elaine%20C%20O%27Sullivan", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland." } }, { "@type": "Person", "name": "Florence O McCarthy", "url": "https://questionsmedicales.fr/author/Florence%20O%20McCarthy", "affiliation": { "@type": "Organization", "name": "School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland." } }, { "@type": "Person", "name": "Hao Lu", "url": "https://questionsmedicales.fr/author/Hao%20Lu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China." } }, { "@type": "Person", "name": "Manli Liu", "url": "https://questionsmedicales.fr/author/Manli%20Liu", "affiliation": { "@type": "Organization", "name": "Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan, China." } }, { "@type": "Person", "name": "Wenjia Lu", "url": "https://questionsmedicales.fr/author/Wenjia%20Lu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Adopting Lean Management in Quality of Services, Cost Containment, and Time Management.", "datePublished": "2022-08-01", "url": "https://questionsmedicales.fr/article/36037141", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31557/APJCP.2022.23.8.2835" } }, { "@type": "ScholarlyArticle", "name": "But I have no time to read this article! A meta-analytic review of the consequences of employee time management behaviors.", "datePublished": "2022-12-29", "url": "https://questionsmedicales.fr/article/36579835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/00224545.2022.2159302" } }, { "@type": "ScholarlyArticle", "name": "Assessing time processing ability and daily time management in persons with dementia: Psychometric properties of three instruments.", "datePublished": "2022-06-29", "url": "https://questionsmedicales.fr/article/35769002", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1440-1630.12827" } }, { "@type": "ScholarlyArticle", "name": "Perceived clinical competence and predictive role of time management in nursing students.", "datePublished": "2023-09-23", "url": "https://questionsmedicales.fr/article/37783023", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.nepr.2023.103789" } }, { "@type": "ScholarlyArticle", "name": "Time Management Strategies for Addressing Mental Health Concerns in the Pediatric Visit.", "datePublished": "2023-11-01", "url": "https://questionsmedicales.fr/article/37935395", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/19382359-20230906-02" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Carbazoles", "item": "https://questionsmedicales.fr/mesh/D002227" }, { "@type": "ListItem", "position": 6, "name": "Ellipticines", "item": "https://questionsmedicales.fr/mesh/D004611" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Ellipticines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Ellipticines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Ellipticines", "description": "Comment diagnostiquer une tumeur sensible aux ellipticines ?\nQuels tests sont utilisés pour évaluer l'efficacité des ellipticines ?\nLes ellipticines sont-elles utilisées pour tous les types de cancer ?\nQuels signes cliniques indiquent un traitement par ellipticines ?\nComment évaluer les effets secondaires des ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Time+Management#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Ellipticines", "description": "Quels symptômes peuvent indiquer un cancer traité par ellipticines ?\nLes ellipticines provoquent-elles des effets secondaires ?\nComment reconnaître une réaction allergique aux ellipticines ?\nLes ellipticines affectent-elles le système immunitaire ?\nQuels signes indiquent une toxicité des ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Time+Management#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Ellipticines", "description": "Peut-on prévenir les cancers traités par ellipticines ?\nQuels facteurs de risque sont associés aux cancers traités par ellipticines ?\nLes vaccinations peuvent-elles aider à prévenir le cancer ?\nComment un mode de vie sain influence-t-il le risque de cancer ?\nLes examens de santé réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Time+Management#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Ellipticines", "description": "Comment les ellipticines sont-elles administrées ?\nLes ellipticines sont-elles utilisées en monothérapie ?\nQuel est le mécanisme d'action des ellipticines ?\nQuelles sont les alternatives aux ellipticines ?\nComment surveiller l'efficacité du traitement par ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Time+Management#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Ellipticines", "description": "Quelles complications peuvent survenir avec les ellipticines ?\nLes ellipticines peuvent-elles causer des dommages aux organes ?\nComment gérer les effets secondaires graves des ellipticines ?\nLes ellipticines augmentent-elles le risque de récidive du cancer ?\nQuels sont les risques de surdosage d'ellipticines ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Time+Management#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Ellipticines", "description": "Quels sont les principaux facteurs de risque pour les cancers traités par ellipticines ?\nL'hérédité joue-t-elle un rôle dans le risque de cancer ?\nL'alimentation influence-t-elle le risque de cancer ?\nLe stress est-il un facteur de risque pour le cancer ?\nLes infections virales augmentent-elles le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D004611?mesh_terms=Time+Management#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une tumeur sensible aux ellipticines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic est établi par biopsie et analyses histopathologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité des ellipticines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie comme l'IRM et des marqueurs tumoraux sont utilisés." } }, { "@type": "Question", "name": "Les ellipticines sont-elles utilisées pour tous les types de cancer ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles sont principalement efficaces contre certains cancers comme le cancer du poumon." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un traitement par ellipticines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de progression tumorale ou de résistance aux autres traitements peuvent indiquer leur utilisation." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires des ellipticines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires sont évalués par des examens cliniques et des questionnaires de qualité de vie." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un cancer traité par ellipticines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, fatigue, perte de poids et changements d'appétit." } }, { "@type": "Question", "name": "Les ellipticines provoquent-elles des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent causer nausées, vomissements, et troubles hématologiques." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique aux ellipticines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées, démangeaisons ou gonflements peuvent indiquer une allergie." } }, { "@type": "Question", "name": "Les ellipticines affectent-elles le système immunitaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner une immunosuppression, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Quels signes indiquent une toxicité des ellipticines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de toxicité incluent fatigue extrême, saignements inhabituels et jaunisse." } }, { "@type": "Question", "name": "Peut-on prévenir les cancers traités par ellipticines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures préventives incluent un mode de vie sain et des dépistages réguliers." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés aux cancers traités par ellipticines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'exposition à des agents carcinogènes et des antécédents familiaux." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider à prévenir le cancer ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer." } }, { "@type": "Question", "name": "Comment un mode de vie sain influence-t-il le risque de cancer ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant alimentation équilibrée et exercice, peut réduire le risque." } }, { "@type": "Question", "name": "Les examens de santé réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter précocement des anomalies et d'initier un traitement rapide." } }, { "@type": "Question", "name": "Comment les ellipticines sont-elles administrées ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement administrées par voie intraveineuse ou orale." } }, { "@type": "Question", "name": "Les ellipticines sont-elles utilisées en monothérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent être utilisées seules ou en association avec d'autres traitements anticancéreux." } }, { "@type": "Question", "name": "Quel est le mécanisme d'action des ellipticines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elles agissent en interférant avec l'ADN des cellules cancéreuses, inhibant leur prolifération." } }, { "@type": "Question", "name": "Quelles sont les alternatives aux ellipticines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les alternatives incluent d'autres chimiothérapies, thérapies ciblées et immunothérapies." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité du traitement par ellipticines ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est surveillée par des examens d'imagerie et des bilans sanguins réguliers." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les ellipticines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des saignements et des réactions allergiques." } }, { "@type": "Question", "name": "Les ellipticines peuvent-elles causer des dommages aux organes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des toxicités hépatiques et rénales, nécessitant une surveillance." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires graves des ellipticines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut l'ajustement de la dose, l'utilisation de médicaments symptomatiques et le suivi." } }, { "@type": "Question", "name": "Les ellipticines augmentent-elles le risque de récidive du cancer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire le risque de récidive, mais un suivi régulier est essentiel." } }, { "@type": "Question", "name": "Quels sont les risques de surdosage d'ellipticines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le surdosage peut entraîner des effets toxiques graves, nécessitant une intervention médicale immédiate." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les cancers traités par ellipticines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'âge." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans le risque de cancer ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer augmentent le risque de développer certaines tumeurs." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le risque de cancer ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque pour le cancer ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Bien que le stress ne soit pas un facteur direct, il peut affecter le système immunitaire." } }, { "@type": "Question", "name": "Les infections virales augmentent-elles le risque de cancer ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections virales, comme le HPV, sont liées à un risque accru de cancer." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 29/03/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Elaine C O'Sullivan

2 publications dans cette catégorie

Affiliations :
  • School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland.

Florence O McCarthy

2 publications dans cette catégorie

Affiliations :
  • School of Chemistry and Analytical and Biological Chemistry Research Facility, University College Cork, Western Road, Cork T12 K8AF, Ireland.

Hao Lu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.

Manli Liu

2 publications dans cette catégorie

Affiliations :
  • Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan, China.

Wenjia Lu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.

Chenchen Wang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.

Gaoyan Wang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.

Wenqi Dong

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.

Xiangru Wang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.

Huanchun Chen

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Preventive Veterinary Medicine in Hubei Province, The Cooperative Innovation Center for Sustainable Pig Production, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.

Chen Tan

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture of the People's Republic of China, Wuhan, China.
  • International Research Center for Animal Disease, Ministry of Science and Technology of the People's Republic of China, Wuhan, China.
  • Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan, China.

Radek Indra

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40, Prague 2, Czech Republic.

Volker M Arlt

2 publications dans cette catégorie

Affiliations :
  • Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, 150 Stamford Street, London, SE1 9NH, United Kingdom; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards at King's College London in partnership with Public Health England and Imperial College London, 150 Stamford Street, London, SE1 9NH, United Kingdom.

Jingjing Lin

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Mei Tang

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Ru Zhao

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Qianqian Du

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Longying Shen

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Guohua Du

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Yafen Zhang

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Sources (10000 au total)

Adopting Lean Management in Quality of Services, Cost Containment, and Time Management.

This study aims to identify the role of adopting lean management in the quality of service, cost containment, and time management and to identify factors affecting lean management adoption, quality of... A cross-sectional design was adopted in this study at the King Hussein Cancer Center (KHCC), a private institution in Amman, Jordan. A convenience sampling technique was used to select 360 participant... Lean management adoption had a significant impact on quality of service, cost containment, and time management in oncology settings....

Assessing time processing ability and daily time management in persons with dementia: Psychometric properties of three instruments.

Persons with dementia experience time-related problems, but there is a lack of instruments evaluating their time processing ability and daily time management. This study aimed to evaluate the psychome... Persons with dementia (n = 53) and their significant others (n = 49) participated in the study. Rasch analyses were used to evaluate the instruments' rating scale functioning; internal scale validity;... Overall, the Rasch analyses showed acceptable psychometric properties. All instruments met the criteria for unidimensionality and the reliability was good. More challenging items should be added in Ka... The instruments can validly and reliably be used to assess time processing ability and daily time management in persons with dementia in clinical research and healthcare settings. In turn, this can co...

Perceived clinical competence and predictive role of time management in nursing students.

The purpose of this study was to determine the association between perceived clinical competence and time management among nursing students.... Given the close relationship between clinical competence and nursing care quality, it is important to investigate the nursing students' status in relation to the acquisition of nursing skills. Time ma... A cross-sectional and correlational study SETTINGS/PARTICIPANTS: This study included 221 undergraduate nursing students in Ahvaz Jundishapur University of Medical Sciences in Iran in the 2022-2023 aca... The data were collected online through a demographic information questionnaire, the clinical competency inventory, and the time management questionnaire.... Students' mean scores for the clinical-competency, and time management were 120.38 ± 22.15, and 77.91 ± 15.15, respectively. Regression models showed that overall time management (β = 0.454, p < 0.001... Time management can affect nursing students' competence in providing quality nursing care to patients. Therefore, it seems that holding training workshops on time management skills for nursing student...

Daily time management in dementia: qualitative interviews with persons with dementia and their significant others.

Persons with dementia encounter time-related problems and significant others often need to provide support in daily time management and use of time assistive technology (AT). Further research has been... Semi-structured interviews with persons with mild to moderate dementia (n = 6) and significant others (n = 9) were conducted three months after receiving prescribed time AT. Interviews were analysed u... A main category "Support by significant others is always part of daily time management", and three categories "Facing new challenges", "Using strategies to handle changes", and "Time assistive technol... Time-related assessments and interventions should be offered at an early stage of dementia to increase the possibility of maintaining daily time management skills. Using time AT to communicate time mi...

Developing time management with preclinical dental students via a preclinical exercise in an organization.

Developing time management is an important aspect of a dental student's passage to clinical care and in their growth as a professional. Suitable time management and preparedness can potentially impact... Students completed five-time management exercises during the term preceding their entrance into the predoctoral restorative clinic which included appointment planning and organization, and reflection ... Students reported a statistically significant increase in their self-confidence of clinical readiness after completion of the time management series, and all students completed the surveys. The themes... It was determined that the time management exercises were effective for the students as they transitioned to treating patients in the predoctoral clinic and can be used for future classes to increase ...

Effect of the Management in Nursing course on students' time management and career planning attitudes: A single-group pre-test post-test study.

This study aimed to determine the effect of the Management in Nursing course on the time management and career planning attitudes of nursing students.... University education is important for young people to develop their time management skills, plan their careers, and implement these plans.... This is a semi-experimental study used single-group pre-test post-test design.... This study sample included 133 fourth-year nursing students who enrolled for the Management in Nursing course in the 2019-2020 academic year. Introductory Information Form, Career Futures Inventory (C... A statistically significant difference was found between the pre- and post-test time planning and TMQ scores. Moreover, a significant difference was found between the pre- and post-test career adaptab... The results of this study indicated that the Management in Nursing course improved the time management skills of fourth-year nursing students as well as increased adaptability and optimism in their ca...

Not too fast, not too slow: A review of historical trends in vaginal breech time management.

A lack of consistent professional guidance on when to intervene during emergence (buttocks and anus visible at the introitus to birth of the head) in vaginal breech birth (VBB).... Hypoxia and asphyxia are common complications of VBB, especially due to umbilical cord compression around the time of emergence.... To gain insight into VBB time management trends, the evidence behind these practices and how they may have influenced outcomes.... Literature review of obstetric textbooks published between 1960 and 2000 contained in the Wellcome Collection and Royal College of Obstetricians and Gynaecologists Library in London.... 90 textbooks were reviewed. Recommendations for 'safe' intervals between birth of the umbilicus and the head ranged from 5 to 20 min. Many sources focused only on the time required to deliver the head... These findings demonstrate a long-term pattern across the second half of the 20th century, whereby birth attendants were urged not to rush emergence nor delay intervention but were given little clear ... Clear, evidence-based guidance should be provided in breech training materials to avoid unnecessary hypoxic injuries, and this guidance should be rigorously evaluated....